The new name will be effective upon closing of the combination, which is expected to occur in mid-2020. More information regarding Viatris, including the company’s full executive management team, board of directors, stock symbol, and logo will be available at a later date. More information regarding Viatris, including the company’s full executive management team, board of directors, stock symbol, and logo will be available at a later date. MORGANTOWN -- Mylan and Upjohn revealed the logo for their new combined company – Viatris – on Thursday and explained a Subscribe or log … Viatris (pronounced 'viǝ-trīs) is Latin for "three paths," and the logo visually captures the company's commitment to access, leadership and partnership. 3 Speen Street, Suite 300, Framingham, MA 01701 No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. Factors that could cause or contribute to such differences include, but are not limited to: ongoing challenges and uncertainties posed by the COVID-19 pandemic for businesses and governments around the world; the parties' ability to meet expectations regarding the timing, completion and accounting and tax treatments of the proposed transaction; changes in relevant tax and other laws; the parties' ability to consummate the proposed transaction; the conditions to the completion of the proposed transaction not being satisfied or waived on the anticipated timeframe or at all; the regulatory approvals required for the proposed transaction not being obtained on the terms expected or on the anticipated schedule or at all; inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements and the providing of estimates of financial measures, in accordance with accounting principles generally accepted in These communications shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. “We are creating a company unlike any other – a company focused on building a more hopeful and sustainable healthcare journey, empowering patients to live healthier at every stage of life.”“The name Viatris communicates the strength of our companies’ combined heritage and our shared goal to provide the highest-quality medicines to the most patients possible,” said Michael Goettler, Group President, Upjohn, who will serve as Chief Executive Officer of Viatris, as previously announced.
Viatris' platform will provide a unique Global Healthcare Gateway™ that will offer partners ready access to more markets and patients worldwide. The news comes just months after GSK's rival IL-5 inhibitor Nucala touted a similar clinical trial win.The FDA approved Trelegy Ellipta as a maintenance therapy for asthma, making it the first once-daily inhaler of its kind approved for those patients.Enclose phrases in quotes. Announcement follows Mylan shareholder approval of Mylan's combination with Pfizer's UpjohnExperience the interactive Multichannel News Release here: Viatris will benefit from Mylan and Upjohn's trusted global offerings and legacy of meeting patient needs around the world. Viatris will benefit from Mylan and Upjohn’s trusted global offerings and legacy of meeting patient needs around the world. The "three paths" work together in harmony and encircle a simplified globe to illustrate the company's core purpose of empowering people worldwide to live healthier at every stage of life. Also no guidance yet if the stock will trade on NYSE:PFE or NASDAQ:MYL. In connection with the proposed transaction, Newco and Mylan have filed certain materials with the Investor Relations, Mylan, Melissa Trombetta,+1 (724) 514-1813, InvestorRelations@mylan.com, Pfizer, Ryan Crowe, +1 (212) 733-8160, Ryan.Crowe@Pfizer.com, Media Relations, Mylan, Christine Waller, +1 (724) 514-1968, Communications@mylan.com, Pfizer, Amy Rose, +1 (212) 733-7410, Amy.Rose@Pfizer.com Future Viatris Executive Chairman and current Mylan Executive Chairman Future Viatris Chief Executive Officer and current The two businesses will continue to operate as independent, separate organizations until close. Future Viatris Executive Chairman and current Mylan Executive Chairman Future Viatris Chief Executive Officer and current Upjohn Group President The two businesses will continue to operate as independent, separate organizations until close. Their merger isn't official yet, but a new logo is ready to go.The reveal comes as the companies await Federal Trade Commission approval for their merger—now expected in the second half of this year—and a week after Mylan's shareholders gave the deal their blessing.Also part of the new image? In connection with the proposed transaction, Newco and Mylan have filed certain materials with the SEC, including, among other materials, the Form S-4, Form 10 and Prospectus filed by Newco and the Proxy Statement filed by Mylan. Mylan and Pfizer announced that the name of the new company to be formed by the planned combination of Mylan and Upjohn, a division of Pfizer, will be Viatris. More information regarding Viatris, including the company’s full executive management team, board of directors, stock symbol, and logo will be available at … The Form S-4 was declared effective on Viatris (pronounced 'viǝ-trīs) is Latin for "three paths," and the logo visually captures the company's commitment to access, leadership and partnership. The new logo and branding is designed to reflect Viatris' guiding principles that will redefine the healthcare landscape through its capability, commitment and vision to address evolving healthcare needs. All rights reserved. Viatris' platform will provide a unique Global Healthcare Gateway™ that will offer partners ready access to more markets and patients worldwide.